These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 25892679)

  • 41. Effectiveness of an integrated telehealth service for patients with depression: a pragmatic randomised controlled trial of a complex intervention.
    Salisbury C; O'Cathain A; Edwards L; Thomas C; Gaunt D; Hollinghurst S; Nicholl J; Large S; Yardley L; Lewis G; Foster A; Garner K; Horspool K; Man MS; Rogers A; Pope C; Dixon P; Montgomery AA
    Lancet Psychiatry; 2016 Jun; 3(6):515-25. PubMed ID: 27132075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
    Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial.
    Kalra L; Irshad S; Hodsoll J; Simpson M; Gulliford M; Smithard D; Patel A; Rebollo-Mesa I;
    Lancet; 2015 Nov; 386(10006):1835-44. PubMed ID: 26343840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The structured ambulatory post-stroke care program for outpatient aftercare in patients with ischaemic stroke in Germany (SANO): an open-label, cluster-randomised controlled trial.
    Schwarzbach CJ; Eichner FA; Rücker V; Hofmann AL; Keller M; Audebert HJ; von Bandemer S; Engelter ST; Geis D; Gröschel K; Haeusler KG; Hamann GF; Meisel A; Sander D; Schutzmeier M; Veltkamp R; Heuschmann PU; Grau AJ;
    Lancet Neurol; 2023 Sep; 22(9):787-799. PubMed ID: 37459876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 'Better wear out sheets than shoes': a survey of 202 stroke professionals' early mobilisation practices and concerns.
    Skarin M; Bernhardt J; Sjöholm A; Nilsson M; Linden T
    Int J Stroke; 2011 Feb; 6(1):10-5. PubMed ID: 21205235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial.
    Livingston G; Barber J; Marston L; Stringer A; Panca M; Hunter R; Cooper C; Laybourne A; La Frenais F; Reeves S; Manela M; Lambe K; Banerjee S; Rapaport P
    Lancet Psychiatry; 2019 Apr; 6(4):293-304. PubMed ID: 30872010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of a chronic cough management algorithm at the transitional stage from acute to chronic cough in children: a multicenter, nested, single-blind, randomised controlled trial.
    O'Grady KF; Grimwood K; Torzillo PJ; Rablin S; Lovie-Toon Y; Kaus M; Arnold D; Roberts J; Buntain H; Adsett D; King A; Scott M; Anderson J; Toombs M; Chang AB
    Lancet Child Adolesc Health; 2019 Dec; 3(12):889-898. PubMed ID: 31635952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses.
    Freeman D; Lambe S; Kabir T; Petit A; Rosebrock L; Yu LM; Dudley R; Chapman K; Morrison A; O'Regan E; Aynsworth C; Jones J; Murphy E; Powling R; Galal U; Grabey J; Rovira A; Martin J; Hollis C; Clark DM; Waite F;
    Lancet Psychiatry; 2022 May; 9(5):375-388. PubMed ID: 35395204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial.
    Osborn D; Burton A; Hunter R; Marston L; Atkins L; Barnes T; Blackburn R; Craig T; Gilbert H; Heinkel S; Holt R; King M; Michie S; Morris R; Morris S; Nazareth I; Omar R; Petersen I; Peveler R; Pinfold V; Walters K
    Lancet Psychiatry; 2018 Feb; 5(2):145-154. PubMed ID: 29396118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fitness and mobility training in patients with Intensive Care Unit-acquired muscle weakness (FITonICU): study protocol for a randomised controlled trial.
    Mehrholz J; Thomas S; Burridge JH; Schmidt A; Scheffler B; Schellin R; Rückriem S; Meißner D; Mehrholz K; Sauter W; Bodechtel U; Elsner B
    Trials; 2016 Nov; 17(1):559. PubMed ID: 27881152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
    Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial.
    Jensen M; Suling A; Metzner A; Schnabel RB; Borof K; Goette A; Haeusler KG; Zapf A; Wegscheider K; Fabritz L; Diener HC; Thomalla G; Kirchhof P
    Lancet Neurol; 2023 Jan; 22(1):45-54. PubMed ID: 36517170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physical Fitness Training in Patients with Subacute Stroke (PHYS-STROKE): multicentre, randomised controlled, endpoint blinded trial.
    Nave AH; Rackoll T; Grittner U; Bläsing H; Gorsler A; Nabavi DG; Audebert HJ; Klostermann F; Müller-Werdan U; Steinhagen-Thiessen E; Meisel A; Endres M; Hesse S; Ebinger M; Flöel A
    BMJ; 2019 Sep; 366():l5101. PubMed ID: 31533934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
    Liu X; Dai Q; Ye R; Zi W; Liu Y; Wang H; Zhu W; Ma M; Yin Q; Li M; Fan X; Sun W; Han Y; Lv Q; Liu R; Yang D; Shi Z; Zheng D; Deng X; Wan Y; Wang Z; Geng Y; Chen X; Zhou Z; Liao G; Jin P; Liu Y; Liu X; Zhang M; Zhou F; Shi H; Zhang Y; Guo F; Yin C; Niu G; Zhang M; Cai X; Zhu Q; Chen Z; Liang Y; Li B; Lin M; Wang W; Xu H; Fu X; Liu W; Tian X; Gong Z; Shi H; Wang C; Lv P; Tao Z; Zhu L; Yang S; Hu W; Jiang P; Liebeskind DS; Pereira VM; Leung T; Yan B; Davis S; Xu G; Nogueira RG;
    Lancet Neurol; 2020 Feb; 19(2):115-122. PubMed ID: 31831388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial.
    Wilson FP; Shashaty M; Testani J; Aqeel I; Borovskiy Y; Ellenberg SS; Feldman HI; Fernandez H; Gitelman Y; Lin J; Negoianu D; Parikh CR; Reese PP; Urbani R; Fuchs B
    Lancet; 2015 May; 385(9981):1966-74. PubMed ID: 25726515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.
    Bracard S; Ducrocq X; Mas JL; Soudant M; Oppenheim C; Moulin T; Guillemin F;
    Lancet Neurol; 2016 Oct; 15(11):1138-47. PubMed ID: 27567239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial.
    Berge E; Cohen G; Roaldsen MB; Lundström E; Isaksson E; Rudberg AS; Slot KB; Forbes J; Smith J; Drever J; Wardlaw JM; Lindley RI; Sandercock PA; Whiteley WN;
    Lancet Neurol; 2016 Sep; 15(10):1028-34. PubMed ID: 27450474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three-dimensional, task-specific robot therapy of the arm after stroke: a multicentre, parallel-group randomised trial.
    Klamroth-Marganska V; Blanco J; Campen K; Curt A; Dietz V; Ettlin T; Felder M; Fellinghauer B; Guidali M; Kollmar A; Luft A; Nef T; Schuster-Amft C; Stahel W; Riener R
    Lancet Neurol; 2014 Feb; 13(2):159-66. PubMed ID: 24382580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Economic evaluation alongside a phase II, multi-centre, randomised controlled trial of very early rehabilitation after stroke (AVERT).
    Tay-Teo K; Moodie M; Bernhardt J; Thrift AG; Collier J; Donnan G; Dewey H
    Cerebrovasc Dis; 2008; 26(5):475-81. PubMed ID: 18810233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.